These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
865 related articles for article (PubMed ID: 36330513)
1. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer. Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M Front Immunol; 2022; 13():994874. PubMed ID: 36330513 [TBL] [Abstract][Full Text] [Related]
2. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients. Fan Q; Liu B J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531 [TBL] [Abstract][Full Text] [Related]
3. Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients. Zhang F; Zhang R; Zong J; Hou Y; Zhou M; Yan Z; Li T; Gan W; Lv S; Yang L; Zeng Z; Zhao W; Yang M Front Immunol; 2023; 14():1279789. PubMed ID: 37928532 [TBL] [Abstract][Full Text] [Related]
4. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer. Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777 [TBL] [Abstract][Full Text] [Related]
5. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients. Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357 [TBL] [Abstract][Full Text] [Related]
6. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer. Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer. Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319 [TBL] [Abstract][Full Text] [Related]
8. Exploring prognostic potential of long noncoding RNAs in colorectal cancer based on a competing endogenous RNA network. Yang ZD; Kang H World J Gastroenterol; 2020 Mar; 26(12):1298-1316. PubMed ID: 32256018 [TBL] [Abstract][Full Text] [Related]
9. Anoikis-related lncRNA signature predicts prognosis and is associated with immune infiltration in hepatocellular carcinoma. Zhu J; Zhao W; Yang J; Liu C; Wang Y; Zhao H Anticancer Drugs; 2024 Jun; 35(5):466-480. PubMed ID: 38507233 [TBL] [Abstract][Full Text] [Related]
10. Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer. Pang L; Wang Q; Wang L; Hu Z; Yang C; Li Y; Wang Z; Li Y BMC Med Genomics; 2023 Mar; 16(1):58. PubMed ID: 36949429 [TBL] [Abstract][Full Text] [Related]
11. A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma. Song Z; Su M; Li X; Xie J; Han F; Yao J BMC Gastroenterol; 2023 Dec; 23(1):432. PubMed ID: 38066437 [TBL] [Abstract][Full Text] [Related]
12. Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature. Ma W; Zhao F; Yu X; Guan S; Suo H; Tao Z; Qiu Y; Wu Y; Cao Y; Jin F J Transl Med; 2020 Nov; 18(1):442. PubMed ID: 33225954 [TBL] [Abstract][Full Text] [Related]
13. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer. Xiong X; Chen C; Li X; Yang J; Zhang W; Wang X; Zhang H; Peng M; Li L; Luo P Front Oncol; 2023; 13():972558. PubMed ID: 37064115 [TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of long noncoding RNA SNHG15 correlates with liver metastasis and poor survival in colorectal cancer. Huang L; Lin H; Kang L; Huang P; Huang J; Cai J; Xian Z; Zhu P; Huang M; Wang L; Xian CJ; Wang J; Dong J J Cell Physiol; 2019 May; 234(5):7032-7039. PubMed ID: 30317592 [TBL] [Abstract][Full Text] [Related]
15. A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma. Zou W; Wang Z; Wang F; Li L; Liu R; Hu M BMC Cancer; 2021 May; 21(1):608. PubMed ID: 34034689 [TBL] [Abstract][Full Text] [Related]
16. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer. Zhang Z; Wang J; Han W; Zhao L BMC Gastroenterol; 2023 Apr; 23(1):132. PubMed ID: 37081402 [TBL] [Abstract][Full Text] [Related]
17. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
18. A Six-LncRNA Expression Signature Associated with Prognosis of Colorectal Cancer Patients. Zhao J; Xu J; Shang AQ; Zhang R Cell Physiol Biochem; 2018; 50(5):1882-1890. PubMed ID: 30396175 [TBL] [Abstract][Full Text] [Related]
19. An eight-long noncoding RNA expression signature for colorectal cancer patients' prognosis. Zhang L; Chen S; Wang B; Su Y; Li S; Liu G; Zhang X J Cell Biochem; 2019 Apr; 120(4):5636-5643. PubMed ID: 30320902 [TBL] [Abstract][Full Text] [Related]
20. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer. Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]